Members of Penta were delighted to be invited to attend the recent reception to celebrate the announcement of the Takeda Chair in Global Child Health at London School of Hygiene & Tropical Medicine (LSHTM). The memorable occasion took place at the Japanese Embassy in London on 16th May.
More than five million children under the age of five die each year, half of whom die within the neonatal period (birth to one month old), with the next largest number being due to childhood infections such as pneumonia and diarrhea. While the vast majority of these deaths are preventable, key research gaps remain.
The Takeda Chair in Global Child Health enables a ‘rising star’ to bridge research, public policy, and healthcare delivery by developing thought leadership in child survival and health through innovative research, including vaccines, neonatal care, under-nutrition, and infection diagnostics and treatments. Takeda’s donation will enable LSHTM to recruit a world-class researcher and educator to join its innovative academic team as the first holder of the Takeda Chair in Global Child Health. This post will play a critical role in consolidating LSHTM’s child health research across more than 100 countries, accelerating change for one of the biggest global health challenges, and further strengthening LSHTM’s position as a leader in maternal, child and adolescent health.
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 4,500 students and more than 3,000 staff working in over 100 countries.
Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.